Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

IDEX CORP /DE/ (IEX) Form 10-Q — Jul 29, 2026

$IEXForm 10-QFiled Jul 29, 2026, 4:35 PM ET0000832101-26-000022Original filing

IDEX Corporation reported second quarter 2026 net sales of $920.6 million, a 6% increase from the prior year, while net income rose 9% to $143.4 million. Diluted EPS increased 11% to $1.93, driven by robust organic growth of 5% and favorable pricing, partially offset by expected customer rebates related to IEEPA tariff refunds. The Health & Science Technologies segment led the performance with 14% sales growth, fueled by AI-driven demand in data centers and semiconductor markets, along with strength in space and defense. The Fluid & Metering Technologies segment saw modest 2% growth, while Fire & Safety/Diversified Products declined 1% due to lower European rescue demand.

Key figures

Eps
1.93
Revenue
920.6
Net Income
143.4
Revenue Yoy
6%
Cash Position
621.3
Shares Outstanding
73,719,896

Price after filing

1 day: +0.4%7 days: +5.9%30 days: +4.5%

Close on the filing date to close N calendar days later (from $223.83). Historical, not a forecast.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    IDEX CORP /DE/ (IEX) Form 10-Q — Jul 29, 2026: AI Analysis | Signal8